Van Eck Associates Corp Dr Reddys Laboratories LTD Transaction History
Van Eck Associates Corp
- $64.4 Billion
- Q1 2024
A detailed history of Van Eck Associates Corp transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Van Eck Associates Corp holds 501 shares of RDY stock, worth $38,101. This represents 0.0% of its overall portfolio holdings.
Number of Shares
501
Previous 337
48.66%
Holding current value
$38,101
Previous $23,000
56.52%
% of portfolio
0.0%
Previous 0.0%
Shares
17 transactions
Others Institutions Holding RDY
# of Institutions
242Shares Held
23.6MCall Options Held
25.2KPut Options Held
8.5K-
Black Rock Inc. New York, NY2.18MShares$166 Million0.0% of portfolio
-
Royal Bank Of Canada Toronto, A62.16MShares$165 Million0.04% of portfolio
-
Robeco Institutional Asset Management B.V.1.97MShares$150 Million0.32% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.93MShares$147 Million0.22% of portfolio
-
Goldman Sachs Group Inc New York, NY1.56MShares$119 Million0.02% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $12.6B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...